MktsMarkets

Arcutis Biotherapeutics, Inc.
NASDAQ: ARQTKey statistics
ARQT News
Stories mentioning ARQT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 105,398 | 129,503 | 99,219 | 81,504 | 65,846 | 71,360 | 44,755 | 30,858 |
| Cost of Goods Sold | 9,784 | 11,688 | 8,685 | 7,492 | 8,830 | 6,905 | 5,503 | 3,464 |
| Gross Profit | 95,614 | 117,815 | 90,534 | 74,012 | 57,016 | 64,455 | 39,252 | 27,394 |
| Operating Expenses | ||||||||
| Research & Development | 30,627 | 20,451 | 19,604 | 19,453 | 17,543 | 14,480 | 19,501 | 19,298 |
| Sales General & Admin | 74,076 | 78,977 | 62,404 | 69,170 | 64,002 | 57,607 | 58,817 | 58,173 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (9,089) | 18,387 | 8,526 | (14,611) | (24,529) | (7,632) | (39,066) | (50,077) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (20.00) | (3,881) | 2,035 | 2,096 | 193.00 | (13,408) | 4,182 | 5,229 |
| Pretax Income | ||||||||
| Tax Provision | 93.00 | 470.00 | 80.00 | 342.00 | 279.00 | 323.00 | 0.00 | 0.00 |
| Net Income (Loss) | (11,295) | 17,395 | 7,410 | (15,886) | (25,060) | (10,788) | (41,537) | (52,332) |
| Earnings Per Share (Basic) | (0.09) | 0.14 | 0.06 | (0.13) | (0.20) | (0.09) | (0.33) | (0.42) |
| Earnings Per Share (Diluted) | (0.09) | 0.14 | 0.06 | (0.13) | (0.20) | (0.09) | (0.33) | (0.42) |
| Weighted Average Shares Outstanding (Basic) | 129.00 | 127,234 | 127,623 | 126,997 | 126.00 | 120,958 | 124,302 | 123,481 |
| Weighted Average Shares Outstanding (Diluted) | 129.00 | 127,234 | 132,885 | 126,997 | 126.00 | 120,958 | 124,302 | 123,481 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ARQT
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is a stock listed on the Nasdaq Stock Market under the ticker symbol ARQT. It last traded at $27.17 (Nov 19, 2026, 4:00 PM ET), down 1.6% on the day. That gives Arcutis Biotherapeutics a market capitalisation of $3.4B and a price-to-earnings ratio of 114.9.
Over the past 52 weeks ARQT has traded between $19.30 and $34.80.
Revenue for the quarter ended Mar 31, 2026 was $105.4M; a net loss of $11.3M. Revenue was up 60.1% from $65.8M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $105.4M | -$11.3M | -10.7% |
| Dec 31, 2025 | $129.5M | $17.4M | 13.4% |
| Sep 30, 2025 | $99.2M | $7.4M | 7.5% |
| Jun 30, 2025 | $81.5M | -$15.9M | -19.5% |
From Arcutis Biotherapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…